Apr 02, 2018|3 min readBy DDNews StaffCariprazine rounds thirdAllergan and Richter announce positive topline results from the Phase 3 trial of cariprazine in Bipolar I depression
Nov 03, 2009|4 min readPlaying in Europe nowPhase Forward inks multi-year data management agreement with European pharma Gedeon Richter
Feb 13, 2018|3 min readBy Mel J. YeatesBeating back the bipolar bluesPrimary endpoint met in study of patients treated with cariprazine for acute bipolar I depression
Feb 08, 2011|2 min readBy Lori LeskoCollaboration combats cystic fibrosisForest acquires rights from Germany’s Grunenthal for CF treatment, prevention